Showing results (391-400 of 420) with videos related to

Sort By:
Pageof 42
Blood|July 9, 1999
Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTPM Galbusera, M Noris, C Rossi, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.
Kidney International|March 31, 2006
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw, D Ramjit, Z Zhang, et al.
Transplantation|February 7, 2001
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantG Dotti, R Fiocchi, T Motta, et al.
Prostaglandins|July 1, 1980
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaG Remuzzi, D Marchesi, C Zoja, et al.
The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Pageof 42